首页|期刊导航|Genes & Diseases|Pan-cancer analysis of ALK mutation and its association with tumor immunogenicity and the efficacy of immune checkpoint blockade

Pan-cancer analysis of ALK mutation and its association with tumor immunogenicity and the efficacy of immune checkpoint blockade

Zhiyang Huang Jiajun Chen Yan Huang Hong Zhao Bin Zhao

Genes & Diseases2026，Vol.13Issue(3)：P.607-616,10.

Genes & Diseases2026，Vol.13Issue(3)：P.607-616,10.DOI:10.1016/j.gendis.2025.101701

Pan-cancer analysis of ALK mutation and its association with tumor immunogenicity and the efficacy of immune checkpoint blockade

Zhiyang Huang ¹Jiajun Chen ¹Yan Huang ¹Hong Zhao ²Bin Zhao¹

作者信息

1. Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou,Fujian 362000,China
2. The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University,Zhuhai,Guangdong 519000,China
折叠

摘要

关键词

ALK/Biomarker/Cancer/Immune checkpoint blockade/Tumor immunogenicity

分类

医药卫生

引用本文复制引用

Zhiyang Huang,Jiajun Chen,Yan Huang,Hong Zhao,Bin Zhao..Pan-cancer analysis of ALK mutation and its association with tumor immunogenicity and the efficacy of immune checkpoint blockade[J].Genes & Diseases,2026,13(3):P.607-616,10.

基金项目

supported by the National Natural Science Foundation of China(No.82373367). （No.82373367）

Genes & Diseases

ISSN：2352-4820

访问量0

下载量0

段落导航